En español
NIDA

Search

Menu

NIDA Notes Articles: Parents

  • Sort by:
  • Date
  • Title
NIDA Notes Category Graphic

Adolescent Cigarette, Alcohol Use Declines as Marijuana Use Rises

February 2013

Fewer teens are using cigarettes, alcohol, and most illicit drugs, according to NIDA’s latest Monitoring the Future study. Troubling  trends persist in marijuana use, however, and nonmedical prescription drug use remains a concern.

NIDA Notes Category Graphic

SAAF‒T Reduces African American Teens’ Substance Use, Conduct Problems

February 2013

Teens who participated in the intervention Strong African American FamiliesTeen at age 16 reported fewer conduct problems and depressive symptoms and less substance abuse at age 17‒18, compared to peers exposed to a control intervention.

NIDA Notes Category Graphic

Brief Intervention Helps Adolescents Curb Substance Use

January 2013

NIDA-funded researchers have gathered evidence that brief interventions can help adolescents move away from drug use. In a clinical trial, middle and high school students markedly reduced their substance use following two 60-minute sessions that combined motivational interviewing and cognitive behavioral therapy.

NIDA Notes Category Graphic

Prenatal Methamphetamine Exposure Linked With Problems

December 2012

Study findings indicate that children exposed to methamphetamine prenatally show more signs of increased emotionality, anxiety, and depression than nonexposed children at ages 3 and 5 years.

NIDA Notes Category Graphic

Animal Research Advances Effort to Develop Vaccines Against Cocaine, Heroin Abuse

September 2012

New vaccines that aim to promote recovery from cocaine and heroin abuse showed promise in animal testing. Both vaccines induced rats’ immune system to produce high titers of antibodies that inhibit the target drug from reaching the brain. The rats’ behaviors when given access to the target drug indicated that the vaccines reduced the reinforcing effects that, in recovering people, can cause lapses to turn into relapses.

NIDA Notes Category Graphic

Potential Pain Medication Targets Peripheral Nerves

September 2012

Researchers report a significant advance in the search for medications that can suppress pain but avoid opioids’ abuse potential and other undesirable CNS effects. A new compound reduces mouse responses in animal models of neurogenic and chronic inflammatory (e.g., arthritic) pain. The compound, called UB937, enhances the natural pain-killing activity of the neurotransmitter anandamide, and exerts its analgesic effects entirely in peripheral tissues, without entering the brain.

NIDA Notes Category Graphic

Few Teens With Prescription Opioid Use Disorders Receive Treatment

July 2012

Fewer than 12 percent of adolescents who meet diagnostic criteria for prescription opioid abuse or dependence receive any treatment, according to an analysis of data from the 2005 to 2008 National Survey on Drug Use and Health. The most common reason the adolescents gave for not receiving treatment was their lack of perceived need for it.

NIDA Notes Category Graphic

Prenatal Cocaine Exposure Increases Monkeys' Impulsivity Into Adulthood

July 2012

Prenatal drug exposure can have behavioral effects that last well into adulthood, according to two studies of adult monkeys prenatally exposed to cocaine. In the first study, drug-exposed monkeys exhibited less flexibility than controls in adjusting to changing circumstances; in the second study, drug-exposed males exhibited a greater preference than controls for having rewards right away, a sign of impulsivity.

NIDA Notes Category Graphic

Adolescent Smoking and Drinking at Historic Lows

July 2012
Rates of adolescent cigarette smoking and alcohol drinking stood at historic lows in 2011, but marijuana use trended upward, according to the Monitoring the Future (MTF) survey.

NIDA Notes Category Graphic

Prevention System Has Lasting Effects, Benefit Exceeds Costs

July 2012

Towns that implemented a drug abuse prevention program called Communities That Care will see a return of $5.30 for each $1 they invested during the 5-year trial of the intervention, according to a cost-benefit analysis. The estimate is based on reductions in smoking and delinquency observed during the fourth year of the study among eighth-graders and the projected total costs of smoking, delinquency, and crime avoided over the lifetimes of study participants.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics